SEP 06, 2017 05:49 AM PDT

Blood 'Fingerprint' Reveals Alzheimer's Status

WRITTEN BY: Xuan Pham

If there was a blood test that could diagnose Alzheimer’s disease, would you take it? For some researchers, the question is not if, but when. A team in the UK recently announced an Alzheimer’s blood test with the highest accuracy rate to date.

Image credit: wikipedia.org

Alzheimer’s disease affects a staggering 44 million people worldwide, yet the diagnosis of this devastating disease remains complicated and uncertain at times.

Currently, diagnosing Alzheimer’s disease in living patients is limited and time-consuming. Most tests focus on symptoms of dementia. Doctors and experts have to conduct a battery of cognitive tests to look for impairments in cognition, memory, social functioning, and behaviors. These tests are highly subjective, but can be supported with neuroimaging data, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. However, such methods are expensive and have limited accuracy. True Alzheimer’s diagnoses are confirmed when post-mortem brain autopsies reveal the presence of beta-amyloid plaques and neurofibrillary tangles – neurological features that are considered hallmarks of the disease. A blood-based test that’s quick and accurate could be a game-changer for patients.

To that end, researchers at the University of Central Lancashire in the United Kingdom turned to a technique called vibrational spectroscopy. Combined with blood-based samples, the technique provides a “spectral fingerprint” of the samples.

This is "a sensor-based technology that has at its core a diamond," explained Dr. Francis Martin, the study’s senior author. "Light is passed through the diamond and bounces off the surface of the diamond. As it does so, the light interacts with chemical bonds in the sample and these vibrate at a frequency that is detected."

This means the blood of someone with Alzheimer’s disease would generate a different pattern than a healthy individual. And such pattern could sound the alarm bells so that patients can receive treatments earlier.

The team tested their technique in nearly 550 people, 347 of whom had been diagnosed with a neurodegenerative disease. The experimental blood test correctly identified Alzheimer’s disease with 86 percent sensitivity and specificity. Moreover, the test had even higher accuracy (90 percent sensitivity and specificity) when teasing apart Alzheimer’s from dementia with Lewy bodies, another neurodegenerative disease.

The “accuracy is markedly higher than other tests being developed,” remarked Dr. Martin. “For such a simple test to be so predictive is very exciting."

He also hinted that the technique’s success could be translated into the clinic in the next decade. "We have now gone well beyond pilot studies," Martin said. "The appropriate validation studies are next -- these will take five to 10 years."

Along with high-risk people (those genetically predisposed for neurodegeneration), Martin sees the blood test as a useful tool for athletes prone to head injuries. Their blood-based test would allow doctors to "monitor disease progression, tailor treatment based on disease classification and predict progression," Martin explained.

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 23, 2018
Cancer
APR 23, 2018
UroSEEK: Early Bladder and Urothelial Cancer Urine Screening Test Developed to Complement Urine Cytology
New, non-invasive urine screening test called UroSEEK was developed by Johns Hopkins to detect low grade bladder and urothelial cancers using DNA detection methods and technology....
MAY 22, 2018
Cancer
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
MAY 29, 2018
Microbiology
MAY 29, 2018
Environmental Factors Drive Belly Fat Buildup
Abdominal fat is a major risk factor for disease. New work could help find those at risk for increased belly fat, and help reverse that trend....
MAY 30, 2018
Cell & Molecular Biology
MAY 30, 2018
Diagnosing Deadly Kidney Cancers Sooner
Researchers have found that deadly kidney cancers can be identified by assessing their evolutionary path, which is different for distinct types....
JUN 21, 2018
Clinical & Molecular DX
JUN 21, 2018
Unique Gene Signature in the Blood Indicates TB Diagnosis
A unique series of genes could tell doctors that a person will develop a tuberculosis (TB) infection months before symptoms are visible. From The Francis C...
JUL 03, 2018
Clinical & Molecular DX
JUL 03, 2018
Blood Test Deciphers Your Internal Rhythm
A personalized reading of your circadian rhythm could help scientists prescribe the exact time of day that drug treatments will be the most effective. A ne...
Loading Comments...